Market Place
Sourcing Support
aTyr Pharma Reveals 2025 Financial Results And Corporate Update
05 Mar 2026 //
GLOBENEWSWIRE
aTyr Pharma Presents At Leerink Partners Healthcare Conference
18 Feb 2026 //
GLOBENEWSWIRE
aTyr Pharma Schedules FDA Type C Meeting For Efzofitimod Program
03 Feb 2026 //
GLOBENEWSWIRE
atyr Pharma Presents At Piper Sandler Healthcare Conference
10 Nov 2025 //
GLOBENEWSWIRE
aTyr Pharma Reveals Q3 2025 Results & Corporate Update
06 Nov 2025 //
GLOBENEWSWIRE
Atyr Pharma Unveils Phase 3 Efzo-Fit™ Study Results At ERS
30 Sep 2025 //
GLOBENEWSWIRE
ATyr Pharma Reveals Inducement Grants per Nasdaq LR 5635(c)(4)
05 Sep 2025 //
GLOBENEWSWIRE
ATyr Pharma Unveils Q2 2025 Results, Updates on Corporate
07 Aug 2025 //
GLOBENEWSWIRE
aTyr Completes Phase 3 EFZO-FIT™ Study on Pulmonary Sarcoidosis
22 Jul 2025 //
GLOBENEWSWIRE
aTyr Pharma to Join Russell 2000 and 3000 Indexes
26 Jun 2025 //
GLOBENEWSWIRE
aTyr Shares Interim Ph 2 Efzofitimod Data in SSc-ILD Study
04 Jun 2025 //
GLOBENEWSWIRE
aTyr Pharma to Present at Upcoming Investor Conferences
20 May 2025 //
GLOBENEWSWIRE
aTyr Pharma Presents Efzofitimod Posters at ATS 2025 Conference
19 May 2025 //
GLOBENEWSWIRE
aTyr Pharma Advances ATYR0101 as IND Candidate for Fibrosis
14 May 2025 //
GLOBENEWSWIRE
aTyr Pharma Announces Q1 2025 Results and Corporate Update
07 May 2025 //
GLOBENEWSWIRE
aTyr Pharma Presents Preclinical Data for NRP2-Targeting Antibody
29 Apr 2025 //
GLOBENEWSWIRE
aTyr Pharma Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
27 Mar 2025 //
GLOBENEWSWIRE
aTyr Pharma: 4th Positive DSMB Review for Efzofitimod in Phase 3
06 Mar 2025 //
GLOBENEWSWIRE
aTyr To Webcast Q4, Full-Year 2024 Financial Results Call
04 Mar 2025 //
GLOBENEWSWIRE
aTyr Pharma to Present at Leerink Partners Conference
24 Feb 2025 //
GLOBENEWSWIRE
aTyr to Present 3 Posters for Efzofitimod at ATS 2025 Conference
29 Jan 2025 //
GLOBENEWSWIRE
aTyr Pharma to Present at 43rd Annual J.P. Morgan Conference
17 Dec 2024 //
GLOBENEWSWIRE
aTyr Pharma Appoints Eric Benevich To Board Of Directors
12 Dec 2024 //
GLOBENEWSWIRE
aTyr Pharma Gets Third Positive DSMB Review For Efzofitimod
10 Dec 2024 //
GLOBENEWSWIRE
aTyr Pharma to Present Anti-Fibrotic Research in Kidney Fibrosis
09 Dec 2024 //
GLOBENEWSWIRE
aTyr Pharma to Present ATYR0101 Data at Keystone Fibrosis Conf
15 Nov 2024 //
GLOBENEWSWIRE
aTyr Pharma Announces Q3 2024 Results & Provides Corporate Update
07 Nov 2024 //
GLOBENEWSWIRE
aTyr`s Efzofitimod To Be Featured At CHEST 2024 Annual Meeting
08 Oct 2024 //
GLOBENEWSWIRE
aTyr Pharma Publishes Efzofitimod in Pulmonary Sarcoidosis
02 Oct 2024 //
GLOBENEWSWIRE
aTyr Pharma to Participate in September Investor Conferences
21 Aug 2024 //
GLOBENEWSWIRE
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
13 Aug 2024 //
GLOBENEWSWIRE
aTyr To Present Efzofitimod Mechanism Of Action Poster At ATS 2024
15 May 2024 //
GLOBENEWSWIRE
aTyr Pharma Announces Positive DSMB Review For Efzofitimod Phase 3
14 May 2024 //
GLOBENEWSWIRE
aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod
13 Nov 2023 //
GLOBENEWSWIRE
aTyr Pharma Announces Dosing of First Patient in Phase 2 Study of Efzofitimod
31 Oct 2023 //
GLOBENEWSWIRE
aTyr Presents Efzofitimod Data Showing Improvements in Patient Reported Outcomes
11 Sep 2023 //
GLOBENEWSWIRE
aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod
20 Jun 2023 //
GLOBENEWSWIRE
aTyr Pharma Presents New Data on Efzofitimod Mechanism of Action
22 May 2023 //
GLOBENEWSWIRE
aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810
17 Apr 2023 //
GLOBENEWSWIRE
aTyr Pharma Announces First Major Review Article for Efzofitimod Published
30 Mar 2023 //
GLOBENEWSWIRE
aTyr Pharma to Present Data Identifying Fibrosis Target for ATYR0101
21 Mar 2023 //
GLOBENEWSWIRE
aTyr Pharma Announces Phase 2 Study of Efzofitimod in Patients with (SSc-ILD)
01 Mar 2023 //
GLOBENEWSWIRE
aTyr Pharma to Present New Data on the Mechanism of Action of Efzofitimod
31 Jan 2023 //
GLOBENEWSWIRE
aTyr Pharma Gains E.U. Patent Covering Use of Efzofitimod with Pirfenidone
19 Jan 2023 //
GLOBENEWSWIRE
Lonza Partners with aTyr Pharma for mAb Manufacturing
14 Apr 2021 //
PHARMTECH
